
Cocrystal Pharma, Inc.
COCPHealthcare|Biotechnology|US
$1.04
+0.04 (+4.00%)
DCF Value
$0.47
Tangible Book / Share
$0.08
Cash / Share
$0.16
Next Earnings Report
Nov 13, 2026
EPS est. -$0.17 · Revenue est. $105.0K
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Apr 23, 2026 (S-3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
Sep 9, 2026 · GlobeNewsWire
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
Aug 17, 2026 · GlobeNewsWire
SEC Filings (65)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 6, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 9, 2026 | 8-K | Material event | DocumentIndex |
| Aug 18, 2026 | 8-K | Material event | DocumentIndex |
| Aug 17, 2026 | 8-K | Material event | DocumentIndex |
| Aug 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 7, 2026 | SC 13D | Activist / 5%+ stake | DocumentIndex |
| Aug 7, 2026 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Aug 3, 2026 | 8-K | Material event | DocumentIndex |
| Jul 17, 2026 | 8-K | Material event | DocumentIndex |
| Jun 9, 2026 | 8-K | Material event | DocumentIndex |
| Jun 3, 2026 | 8-K | Material event | DocumentIndex |
| May 27, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| May 27, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 26, 2026 | 8-K | Material event | DocumentIndex |
| May 15, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 1, 2026 | EFFECT | DocumentIndex | |
| Apr 30, 2026 | 8-K | Material event | DocumentIndex |
| Apr 23, 2026 | S-3 | Shelf registration | DocumentIndex |
| Apr 2, 2026 | 8-K | Material event | DocumentIndex |
| Mar 31, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 31, 2026 | 8-K | Material event | DocumentIndex |
| Mar 13, 2026 | 8-K | Material event | DocumentIndex |
| Mar 9, 2026 | 8-K | Material event | DocumentIndex |
| Feb 19, 2026 | 8-K | Material event | DocumentIndex |
| Jan 15, 2026 | 8-K | Material event | DocumentIndex |
| Dec 18, 2025 | 8-K | Material event | DocumentIndex |
| Dec 1, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Oct 30, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Oct 30, 2025 | 8-K | Material event | DocumentIndex |
| Oct 27, 2025 | 8-K | Material event | DocumentIndex |
| Oct 2, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Sep 29, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Sep 25, 2025 | EFFECT | DocumentIndex | |
| Sep 19, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Sep 15, 2025 | 8-K | Material event | DocumentIndex |
| Sep 15, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 12, 2025 | 8-K | Material event | DocumentIndex |
| Sep 12, 2025 | 8-K | Material event | DocumentIndex |